BR9611488A - Estereoisômero 3r-3'r puro de zeaxantina para o tratamento da degeneração macular em seres humanos - Google Patents

Estereoisômero 3r-3'r puro de zeaxantina para o tratamento da degeneração macular em seres humanos

Info

Publication number
BR9611488A
BR9611488A BR9611488A BR9611488A BR9611488A BR 9611488 A BR9611488 A BR 9611488A BR 9611488 A BR9611488 A BR 9611488A BR 9611488 A BR9611488 A BR 9611488A BR 9611488 A BR9611488 A BR 9611488A
Authority
BR
Brazil
Prior art keywords
stereoisomer
humans
treatment
macular degeneration
zeaxanthin
Prior art date
Application number
BR9611488A
Other languages
English (en)
Inventor
Luis H Guerra-Santos
Dennis L Gierhart
Kevin M Garnett
Original Assignee
Applied Food Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/551,153 external-priority patent/US5827652A/en
Priority claimed from US08/551,166 external-priority patent/US5854015A/en
Application filed by Applied Food Biotech Inc filed Critical Applied Food Biotech Inc
Publication of BR9611488A publication Critical patent/BR9611488A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BR9611488A 1995-10-31 1996-10-30 Estereoisômero 3r-3'r puro de zeaxantina para o tratamento da degeneração macular em seres humanos BR9611488A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/551,153 US5827652A (en) 1995-10-31 1995-10-31 Zeaxanthin formulations for human ingestion
US08/551,166 US5854015A (en) 1995-10-31 1995-10-31 Method of making pure 3R-3'R stereoisomer of zeaxanthin for human ingestion
PCT/US1996/017563 WO1997016175A1 (en) 1995-10-31 1996-10-30 Pure 3r-3'r stereoisomer of zeaxanthin for treating macular degeneration in humans

Publications (1)

Publication Number Publication Date
BR9611488A true BR9611488A (pt) 1999-01-19

Family

ID=27069666

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9611488A BR9611488A (pt) 1995-10-31 1996-10-30 Estereoisômero 3r-3'r puro de zeaxantina para o tratamento da degeneração macular em seres humanos

Country Status (14)

Country Link
JP (1) JPH10512594A (pt)
KR (1) KR100570251B1 (pt)
CN (1) CN1104235C (pt)
AR (1) AR004245A1 (pt)
AU (1) AU710634B2 (pt)
BR (1) BR9611488A (pt)
CZ (1) CZ297575B6 (pt)
FI (1) FI980947A (pt)
HU (1) HU223208B1 (pt)
NO (1) NO981698L (pt)
PL (1) PL185465B1 (pt)
RU (1) RU2197958C2 (pt)
WO (1) WO1997016175A1 (pt)
ZA (1) ZA969139B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8088363B2 (en) 2002-10-28 2012-01-03 Zeavision Llc Protection against sunburn and skin problems with orally-ingested high-dosage zeaxanthin
GB0501365D0 (en) * 2005-01-21 2005-03-02 Promar As Compositions
US8592662B2 (en) 2005-02-11 2013-11-26 Kalamazoo Holdings, Inc. Capsicum variety exhibiting a hyper-accumulation of zeaxanthin and products derived therefrom
EP2329815A1 (en) * 2005-02-11 2011-06-08 Kalamazoo Holdings, Inc. A capsicum variety exhibiting a hyper-accumulation of zeaxanthin and products derived therefrom

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US308759A (en) * 1884-12-02 Curling hat-brims and machine therefor
WO1991003571A1 (en) * 1989-08-30 1991-03-21 Applied Food Biotechnology, Inc. Production of zeaxanthin and zeaxanthin-containing compositions
US5310764A (en) * 1992-05-08 1994-05-10 Steven Baranowitz Treatment of age related macular degeneration with beta-carotene

Also Published As

Publication number Publication date
AU710634B2 (en) 1999-09-23
PL185465B1 (pl) 2003-05-30
MX9605248A (es) 1998-06-30
HUP9802314A3 (en) 1999-05-28
FI980947A (fi) 1998-04-29
JPH10512594A (ja) 1998-12-02
NO981698L (no) 1998-06-08
AR004245A1 (es) 1998-11-04
KR100570251B1 (ko) 2006-06-21
CZ130998A3 (cs) 1998-07-15
RU2197958C2 (ru) 2003-02-10
PL326558A1 (en) 1998-09-28
HUP9802314A2 (hu) 1999-04-28
HU223208B1 (hu) 2004-03-29
CN1104235C (zh) 2003-04-02
CN1201388A (zh) 1998-12-09
FI980947A0 (fi) 1996-10-30
WO1997016175A1 (en) 1997-05-09
KR19990067180A (ko) 1999-08-16
NO981698D0 (no) 1998-04-16
AU7050196A (en) 1997-05-08
CZ297575B6 (cs) 2007-02-07
ZA969139B (en) 1997-09-25

Similar Documents

Publication Publication Date Title
IL117793A0 (en) Method for the treatment of macular degeneration
AU6974996A (en) Compositions for the treatment of dermatological disorders and methods for their use
AU2002300464A1 (en) Apoliprotein A-I Agonist And Their Use To Treat Dyslipidemic Disorders
NO20004098D0 (no) FremgangsmÕter og preparater for behandling av makrofag- formidlede lidelser
BR9503489A (pt) Aparelho de jogo para uma televisao e método para controle do aparelho de jogo para uma televisao
EE9900014A (et) Erütromütsiinid ja nende valmistamise protsess
BR9106891A (pt) Composiçoes para o tratamento da pele
AU4104896A (en) Stable lycopene concentrates and process for their preparation
AU6801694A (en) The treatment of small animals
AU7050898A (en) Process and means for the eradication of ticks in the habitats of small mammals
AU2027695A (en) Pharmaceutical composition for treating stoma-peripheral inflammation diseases
BR9405698A (pt) Composições tópicas para o olho compreendendo um derivado de beta-ciciodextrina e um agente terapêutico
AU6522396A (en) Composition for cleaning or treating human or animal hair
ATE186541T1 (de) Quillajasaponin-zusatz und diesen enthaltende impfstoffformulierung
AU2804297A (en) Method of and composition for treating disorders of the skin using vitamin k
PL317579A1 (en) Benzopyranes and their application as therapeutic agents
BR9701672A (pt) Processo para a preparação de ácidos ciclo-alcano-indol-e azaindol-e pirimido(1,2a)-indol-carboxílicos enantiomericamente puros e seus derivados ativados
BR9403430A (pt) Composição aquosa para tratamento da madeira; e método de tratamento de madeira
BR9611488A (pt) Estereoisômero 3r-3'r puro de zeaxantina para o tratamento da degeneração macular em seres humanos
PT928183E (pt) Utilizacao de 1-hidroxilo-2-piridoneno para o tratamento da dermatite seborroica
AU2068295A (en) Skin treatment composition
AUPN104895A0 (en) Methods of and preparations for the treatment of ailments and disorders
AU5963396A (en) Cis-resorcylide, pharmaceutical composition containing it, use thereof in the treatment of thrombosis and related disorders
AU697136B2 (en) Agents for treating metabolic bone diseases
AU2792695A (en) Amino acid derivatives and their use as pesticides

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIMENTO DO PEDIDO COM BASE NOS ART. 8, 13 E 229-A DA LPI VIGENTE.

B12B Appeal against refusal [chapter 12.2 patent gazette]